New trial finds diabetes drug and nasal insulin improve brain health in early Alzheimer's disease

A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes drug empagliflozin (Jardiance) and intranasal insulin, safely improve brain health in people with mild cognitive impairment and early Alzheimer's disease.

Leaked Group Chat from Young Republicans Rocks Washington D.C. - But Here's The Crux of the Issue
- ‘He Was Sending Seniors To Their Death’: Socialist Zohran Mamdani Downplays Anti-Police Tweets - Anthony Iafrate
- Debit Card Fraud Is on the Rise. Here’s What I Did When It Happened to Me
- Elon Musk's Ambitious Plan: To Send One Million Humans to Mars within the Next Decade - Michael A. Medeiros
- “Screwworm is dangerously close”: Flesh-eating parasites just 70 miles from US - Beth Mole
- The Evolution and Impact of Internet Jokes: A Closer Look at Prank.Chat - Bertha Stephens
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran

Cenk's Nephew TORTURES Dog For Twitch Views
- The Trump Doctrine Is To Have No Doctrine - Daniel J. Flynn
- FDA’s Approval of Mifepristone Generic Raises Troubling Questions - John Gerardi
- 5 Ways to Make Your Canned Tuna Healthier, According to Registered Dietitians - Jamie Ducharme
- Grand Jury Indicts John Bolton on 18 Counts
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- Goodbye, Annie Hall: Legendary Actress Diane Keaton Dead At 79 - Jennifer Asencio